Elo MutualとKorea InvestmentはResMedの株式を増やし、収益予想を上回りました。 Elo Mutual and Korea Investment boosted stakes in ResMed, which beat earnings forecasts.

エロ・ミューチュアル・年金保険会社と 韓国投資株式会社も 医療機器の提供会社である レスメッド社の株を増加させた. Elo Mutual Pension Insurance Co and Korea Investment Corporation both increased their stakes in ResMed Inc., a medical equipment provider. エルオの持分は17.4%増加し,現在は15229株を保有しており,一方韓国の投資株は55.66%上昇し,12626株を保有している. Elo's holdings grew by 17.4%, now owning 15,229 shares, while Korea Investment's holdings rose by 55.6%, owning 127,626 shares. RESMEDの4分の4の収益は1株あたり2.43ドルで,期待される2.29ドルを上回る. ResMed's fourth-quarter earnings per share were $2.43, surpassing the expected $2.29. 会社は329億円の市場キャップを備え,50日の平均移動価格は233.70ドルである. The company has a market cap of $32.29 billion and a 50-day moving average price of $233.70.